TW201534321A - Carbon nanodots, method for synthesizing the same and use of producing pharmaceutical agents for treating liver tumor - Google Patents

Carbon nanodots, method for synthesizing the same and use of producing pharmaceutical agents for treating liver tumor Download PDF

Info

Publication number
TW201534321A
TW201534321A TW103109430A TW103109430A TW201534321A TW 201534321 A TW201534321 A TW 201534321A TW 103109430 A TW103109430 A TW 103109430A TW 103109430 A TW103109430 A TW 103109430A TW 201534321 A TW201534321 A TW 201534321A
Authority
TW
Taiwan
Prior art keywords
carbon nano
dots
point
carbon
supernatant
Prior art date
Application number
TW103109430A
Other languages
Chinese (zh)
Other versions
TWI532493B (en
Inventor
Chi-Lin Li
Huan-Tsung Chang
Chih-Ching Huang
Jin-Shun Cang
Original Assignee
Chi-Lin Li
Lin wei sheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chi-Lin Li, Lin wei sheng filed Critical Chi-Lin Li
Priority to TW103109430A priority Critical patent/TWI532493B/en
Publication of TW201534321A publication Critical patent/TW201534321A/en
Application granted granted Critical
Publication of TWI532493B publication Critical patent/TWI532493B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Carbon And Carbon Compounds (AREA)

Abstract

Carbon nanodots and method for synthesizing the same, wherein the method at least comprises the following steps: providing a ginger juice, heating the ginger juice with a predetermined temperature for a predetermined time period to make the ginger juice carbonized and transformed to carbon nanomaterials containing carbides; centrifuging the carbon nanomaterials containing the carbides to obtain a supernatant; and after filtrating the supernatant, dialyzing the supernatant to obtain a solution of carbon nanodots. In addition, each one of the carbon nanodots synthesized by the above method residues in some curcumin molecules, exhibiting a growth inhibition effect to liver cancer cell. Accordingly, use of producing pharmaceutical agents for treating liver tumor can also be derived from the same.

Description

碳奈米點及其合成方法與其作為製造治療肝腫瘤的醫藥的用途 Carbon nano point and its synthesis method and its use as a medicine for treating liver tumors

本發明乃是關於一種碳奈米點及其合成方法與作為製造治療肝腫瘤的醫藥的用途,特別是關於一種以薑為碳源而進行合成所得的一種碳奈米點,及其合成方法與碳奈米點作為製造治療肝腫瘤的醫藥的用途。 The invention relates to a carbon nano point and a synthetic method thereof, and a use as a medicine for manufacturing a liver tumor, in particular to a carbon nano point obtained by synthesizing ginger as a carbon source, and a synthetic method thereof The use of carbon nano-dots as a medicine for the treatment of liver tumors.

碳奈米點屬於量子點(quantum dot)的一種,一般而言,碳奈米點本身具有光致發光(photoluminescent)的特性,可被不同波長的光激發,以使碳奈米點本身產生不同顏色的螢光。而且碳奈米點還具有高度的水溶性、量子產率(quantum yield)以及光穩定性,因此目前被廣泛應用於生物影像系統及其感測器等相關產業。相較於其他毒性較高的量子點,例如:由鎘(Cd2+)和鉛(Pb2+)等有毒重金屬所衍生的量子點,碳奈米點有相對較小的毒性及高度的生物相容性,因此更適合於生物方面的應用,儘管如此,碳奈米點在生物方面的應用,目前多僅用在關於顯影、偵測的用途,事實上碳奈米點的在生物方面的應用,還有待更進一步的開發,另如抗癌的用途,然而目前抗癌不外乎使用手術切除、放射線或標靶藥物等化學療法,每一種均具有其醫療上的高度風險,而且療程中還會為病患帶來許多副作用,徒增痛苦,後來也有主張使用天然藥物(或草藥)以對抗癌症,但是其無論是在劑型開發上、有效成分萃取上均具有許多難題跟瓶頸待克服,是以由天然藥物作為抗癌 基礎的藥物開發,一直遲遲未能進入成熟的階段。 A carbon nano-dots are one type of quantum dots. In general, carbon nano-dots have photoluminescent properties that can be excited by light of different wavelengths to make the carbon nano-dots themselves different. Fluorescent color. Moreover, carbon nano-dots are also widely used in bio-imaging systems and their related industries, such as high water solubility, quantum yield and light stability. Compared to other highly toxic quantum dots, such as quantum dots derived from toxic heavy metals such as cadmium (Cd 2+ ) and lead (Pb 2+ ), carbon nanotubes have relatively low toxicity and high levels of biology. Compatibility, so it is more suitable for biological applications. However, the biological application of carbon nano-points is currently only used for development and detection purposes. In fact, the biological aspects of carbon nano-dots Application, yet to be further developed, as well as anti-cancer use, but currently anti-cancer is no more than the use of surgical resection, radiation or target drugs and other chemotherapy, each with its medical high risk, and during the course of treatment It will also bring many side effects to patients, increase the pain, and later advocate the use of natural drugs (or herbs) to fight cancer, but it has many problems and bottlenecks to overcome in the development of dosage forms and the extraction of active ingredients. The development of drugs based on natural medicines as an anti-cancer has been slow to enter the stage of maturity.

又,習知的碳奈米點的製造方法可分成兩大類型:化學及物理方法。化學方法主要包括:微波裂解(microwave pyrolysis)、燃燒的途徑(combustion routes)以及電化學氧化(electrochemical oxidation)。物理方法則包括雷射剝蝕(laser ablation)、電弧放電(arc discharge)、高能量的離子束輻射(high-energy ion beam radiation)以及電漿處理(plasma treatment)。然而上述方法的步驟多較為繁雜,且技術難度高,難以掌控所製造的碳奈米點的品質,尤其,使用上述諸方法時,多需要耗費大量的經費以購置昂貴的儀器,或需用到大量不利環境的氧化酸(oxidative acid)。甚至,為了使碳奈米點可以具有光致發光特性,在製造過程中還需要耗費大量長時間的等待,而且有時需要加入表面鈍化劑(passivating agents)處理或額外修飾碳奈米點本身,在這長時間的等待過程中,仍需不斷地消耗大量能源。故可了解,習知的碳奈米點無論在製程簡化、降低成本或環境保護方面,皆有其尚待進步的空間。 Moreover, conventional methods for fabricating carbon nanodots can be divided into two major types: chemical and physical methods. Chemical methods mainly include: microwave pyrolysis, combustion routes, and electrochemical oxidation. Physical methods include laser ablation, arc discharge, high-energy ion beam radiation, and plasma treatment. However, the steps of the above methods are more complicated, and the technical difficulty is high, and it is difficult to control the quality of the manufactured carbon nano-dots. In particular, when using the above methods, it takes a lot of money to purchase expensive instruments, or needs to be used. A large number of unfavorable environmental oxidative acids. Even in order to make the carbon nano-dots have photoluminescence characteristics, it takes a long time to wait in the manufacturing process, and sometimes it is necessary to add surface passivating agents or additionally modify the carbon nano-dots themselves. During this long waiting period, it still needs to consume a lot of energy continuously. Therefore, it can be understood that the conventional carbon nano-point has room for improvement in terms of process simplification, cost reduction or environmental protection.

此外,天然的植物的成分多有可輔助抗癌或抑制腫瘤的成分,例如兒茶素或薑黃素等,以薑黃素為例,其已知可能誘發細胞凋亡因子作用,促使肝癌細胞走向凋亡途徑的化合物,但是其難溶於水的特性,也導致製劑開發的困難,其有效成分較難進入病灶。而在2006年J.Cao等人於Toxicological Sceince所發表關於薑黃素對HepG2細胞株(Human hepatocellular liver carcinoma cell line)的抑制結果而言,其結果顯示,在作用時間範圍24小時、48小時及72小時的狀況下,薑黃素對HepG2達到生長抑制的最低濃度(inhibitory concentration 50%,IC50)值,分別需要高達31.29±0.90μg/ml、22.36±1.45μg/ml以及16.43±1.81μg/ml的濃度才能達成。而薑黃素在製備上多半使用矽膠管柱層析(silica gel column chromatography),此法的技術難度高,不易操作,而且需使用大量有機溶劑以洗滌(elute)與再結晶(recrystallization)出薑黃 素,非常不符合成本及環保效益。 In addition, natural plant components have many anti-cancer or tumor-inhibiting components, such as catechin or curcumin. For example, curcumin is known to induce apoptosis and promote liver cancer cells. Compounds that die, but their poor solubility in water also lead to difficulties in formulation development, and their active ingredients are more difficult to enter the lesion. In 2006, J. Cao et al., in Toxicological Sceince, published the results of inhibition of curcumin on HepG2 cell line (Human hepatocellular liver carcinoma cell line), and the results showed that the action time range was 24 hours, 48 hours and 72 hours. Under the condition of an hour, the minimum inhibitory concentration (50%, IC 50 ) of curcumin on HepG2 needs to be as high as 31.29±0.90μg/ml, 22.36±1.45μg/ml and 16.43±1.81μg/ml, respectively. The concentration can be reached. Curcumin is mostly used in the preparation of silica gel column chromatography. This method is technically difficult and difficult to handle, and requires a large amount of organic solvent to be used for eluting and recrystallization of curcumin. Very inconsistent with cost and environmental benefits.

緣是,本發明人有感上述問題之可改善,乃潛心研究並配合學理之運用,而提出一種設計合理且有效改善上述問題之本發明。 The reason is that the present inventors have felt that the above problems can be improved, and that the present invention has been deliberately studied and used in conjunction with the theory, and a present invention which is reasonable in design and effective in improving the above problems has been proposed.

本發明之主要目的,在於提供一種碳奈米點及其製造方法,以改善目前碳奈米點在製造上所面臨之成本較高、製程繁雜以及製造過程不利於環境保護等問題,並以此碳奈米點衍生出抗癌的應用,以為現今抗癌的策略提供另一全新的技術方案。 The main object of the present invention is to provide a carbon nano point and a manufacturing method thereof, so as to improve the problems of high cost, complicated process and unfavorable environmental protection during the manufacturing process of the carbon nano point. Carbon nano-dots are derived from anti-cancer applications to provide another new technological solution for today's anti-cancer strategy.

為達上述目的,本發明提供一種碳奈米點的製造方法,至少包括如下步驟:(A)提供一薑汁,以一預定溫度對該薑汁加熱一預定時間,以使該薑汁碳化,並形成含有碳化物的碳奈米材料;(B)對該含有碳化物的碳奈米材料進行離心以取得一上清液;以及(C)過濾該上清液後,對該上清液進行透析處理,從而獲得一碳奈米點懸浮溶液。 To achieve the above object, the present invention provides a method for producing a carbon nano point, comprising at least the following steps: (A) providing a ginger juice, heating the ginger juice at a predetermined temperature for a predetermined time to carbonize the ginger juice, And forming a carbon nanomaterial containing carbide; (B) centrifuging the carbide-containing carbon nanomaterial to obtain a supernatant; and (C) filtering the supernatant, and then performing the supernatant Dialysis treatment to obtain a carbon nano point suspension solution.

為達上述目的,本發明提供一種碳奈米點,至少包括:數個結合於該碳奈米點的表面的薑黃素分子。 To achieve the above object, the present invention provides a carbon nano point comprising at least: a plurality of curcumin molecules bound to a surface of the carbon nano point.

為達上述目的,本發明還提供一種以碳奈米點作為製造治療肝腫瘤的醫藥的用途,其中該碳奈米點至少包括:數個結合於該碳奈米點的薑黃素分子,其中該碳奈米點溶於一含水載體。 In order to achieve the above object, the present invention also provides a use of a carbon nano point as a medicine for treating a liver tumor, wherein the carbon nano point comprises at least: a plurality of curcumin molecules bound to the carbon nano point, wherein the The carbon nano point is dissolved in an aqueous carrier.

綜上所述,本發明藉由上述的製造方法可達到大幅降低製造碳奈米點時所需的成本、簡化製程並且兼顧環境保護上的優點,而藉由上述的製造方法,透過以薑為碳源所製造/合成而得之碳奈米點,在製造完成時便已在其表面自然結合有薑黃素分子,且不會在透析的過程中流失掉,並展現出抑制腫瘤生長之抗癌的活性,顯然藉由上述的製造方法,所製造出的碳奈米點,具有不可預期的抗癌活性,可做為現今醫界另一重要選項,以改善目前已知抗癌療法高風險、高副作用等的缺點。 In summary, the present invention can achieve the advantages of greatly reducing the cost required for manufacturing a carbon nano point, simplifying the process, and taking into consideration environmental protection advantages by the above-described manufacturing method, and by the above-mentioned manufacturing method, The carbon nano-dots produced/synthesized by the carbon source have been naturally combined with curcumin molecules on the surface at the time of manufacture, and are not lost during dialysis, and exhibit anti-cancer which inhibits tumor growth. The activity, apparently by the above-mentioned manufacturing method, the carbon nano-dots produced, with unpredictable anti-cancer activity, can be another important option in today's medical community to improve the high risk of currently known anti-cancer therapies, Shortcomings such as high side effects.

為使能更進一步瞭解本發明之特徵及技術內容,請參閱以下有關本發明之詳細說明與附圖,然而所附圖式僅提供參考與說明用,並非用來對本發明加以限制者。 For a better understanding of the features and technical aspects of the present invention, reference should be made to the accompanying drawings.

圖1為本發明碳奈米點的製造方法的步驟流程圖;圖2A為本發明碳奈米點的穿透式電子顯微鏡影像;圖2B為本發明碳奈米點在激發波長325奈米至445奈米之間的螢光放光光譜;圖2C為利用傅立葉轉紅外光譜儀以偵測本發明之碳奈米點上所存在的官能基團的圖譜結果圖;圖2D為利用X光光譜儀對本發明碳奈米點所測得之四個束縛能的結果;圖3A為本發明碳奈米點的X光繞射圖;圖3B為本發明碳奈米點的UV-Vis吸收光譜;圖4A為本發明碳奈米點的碳的1s軌域的X光光電子能譜儀的結果圖;圖4B為本發明碳奈米點的拉曼光譜之結果圖;圖4C為本發明碳奈米點的13C NMR光譜結果圖;圖5A為本發明碳奈米點在pH值3、4、5、6、7、8、9、10之間的螢光放光穩定度的結果圖;圖5B為本發明碳奈米點在氯化鈉濃度0、100、200、300、400、500mM之間的螢光放光穩定度的結果圖;圖5C為本發明碳奈米點經過0至360分鐘的紫外光照射後的螢光放光穩定度的結果圖;圖6為以本發明碳奈米點(1.11mg/mL)添加於A549、HeLa、HepG2、MCF10A及MDA-MB-231之五種細胞株後4小時所呈現之明視野(A欄位)及螢光影像(B欄位)之結果;圖7A為以本發明碳奈米點(0-2.8mg/mL)添加於A549、HeLa、 HepG2、MCF10A及MDA-MB-231之五種細胞株作用24小時後所測得之細胞存活率之結果;圖7B為以本發明碳奈米點(0-2.8mg/mL)添加於A549、HeLa、HepG2、MCF10A及MDA-MB-231之五種細胞株作用24小時後所測得之p53表現之西方墨點法的結果圖;圖7C為以本發明碳奈米點(0-2.8mg/mL)添加於A549、HeLa、HepG2、MCF10A及MDA-MB-231之五種細胞株作用24小時後所測得之細胞週期之分布;圖8為以不同濃度的薑汁添加於A549、HeLa、HepG2、MCF10A及MDA-MB-231之五種細胞株作用24小時後所測得之細胞存活率;圖9 為與本發明之碳奈米比較、對照其抗腫瘤效果,另以EDTA、甘胺酸以及綠茶所製造的碳奈米點分別入加HepG2細胞中,作用24小時後所測得之細胞存活率;圖10為利用影像細胞儀分析A549、HeLa、HepG2、MCF10A及MDA-MB-231之五種細胞株對碳奈米點材料之胞吞效果(橫軸)及ROS產生(縱軸)之情形,其中左邊A欄位為未添加碳奈米點的控制組,右邊B欄位為添加1.11mg/mL碳奈米點之實驗組;圖11為本發明碳奈米點在濃度0.011mg/mL下所測得之SALDI質譜圖,其中較小的插入圖為預測的[薑黃素+H]+同位素的圖譜;圖12A為將107個HepG2細胞接種在小鼠側背所形成的腫瘤,且分別在第7天和第14天,將220μg碳奈米點(共440μg)注射進腫瘤內,箭頭所指處是注射的位置;圖12B為在接種HepG2後第16天所取出的腫瘤的直徑量測結果,左半圖為未注射碳奈米點的控制組,右半圖為有注射碳奈米點的實驗組;以及 圖12C為在接種HepG2後第16天所取出的腫瘤的腫瘤秤重結果之直方圖。 1 is a flow chart showing the steps of a method for producing a carbon nano point of the present invention; FIG. 2A is a transmission electron microscope image of a carbon nano point of the present invention; and FIG. 2B is a carbon nano point of the present invention at an excitation wavelength of 325 nm to Fluorescence spectroscopy spectrum between 445 nm; FIG. 2C is a map of the results of using the Fourier transform infrared spectrometer to detect functional groups present on the carbon nano-dots of the present invention; FIG. 2D is an example using X-ray spectrometer Figure 3A is an X-ray diffraction pattern of a carbon nano-point of the present invention; Figure 3B is a UV-Vis absorption spectrum of a carbon nano-point of the present invention; Figure 4A The result of the X-ray photoelectron spectroscopy of the 1s orbital domain of the carbon of the carbon nano-point of the present invention; FIG. 4B is a result of the Raman spectrum of the carbon nano-dots of the present invention; FIG. 4C is the carbon nano-point of the present invention; Figure 13A is a graph showing the results of fluorescence luminescence stability of the carbon nano-dots at pH values of 3, 4, 5, 6, 7, 8, 9, 10; Figure 5B The result of the fluorescence light emission stability of the carbon nano point of the present invention at a sodium chloride concentration of 0, 100, 200, 300, 400, 500 mM; FIG. 5C is a carbon nene of the present invention; Figure 5 is a graph showing the results of fluorescence luminescence after 0 to 360 minutes of ultraviolet light irradiation; Figure 6 is a carbon nano point (1.11 mg/mL) added to A549, HeLa, HepG2, MCF10A and MDA. The results of the bright field (field A) and the fluorescent image (field B) exhibited by the four cell lines of MB-231 at 4 hours; Fig. 7A shows the carbon nano spot (0-2.8 mg/) of the present invention. mL) results of cell viability measured after 24 hours of action of five cell lines added to A549, HeLa, HepG2, MCF10A and MDA-MB-231; Figure 7B shows the carbon nano-dots of the present invention (0-2.8) Mg/mL) results of the western blot method of p53 expression measured after 24 hours of action on five cell lines of A549, HeLa, HepG2, MCF10A and MDA-MB-231; FIG. 7C is the carbon of the present invention Nano-point (0-2.8mg/mL) was added to the cell cycle distribution of the five cell lines of A549, HeLa, HepG2, MCF10A and MDA-MB-231 after 24 hours; Figure 8 is at different concentrations The ginger cell juice was added to the cell viability of the five cell lines of A549, HeLa, HepG2, MCF10A and MDA-MB-231 for 24 hours; Figure 9 is compared with the carbon nanoparticle of the present invention. Tumor effect In addition, the carbon nano-dots made by EDTA, glycine and green tea were added to HepG2 cells, and the cell viability was measured after 24 hours. Figure 10 shows the analysis of A549, HeLa, HepG2, and MCF10A by image cytometry. And the cellulite effect (horizontal axis) and ROS production (vertical axis) of the five cell lines of MDA-MB-231 on the carbon nano-point material, wherein the left A column is the control group without the carbon nano-dots The B column on the right is the experimental group adding 1.11 mg/mL carbon nano-dots; Figure 11 is the SALDI mass spectrum measured at the concentration of 0.011 mg/mL of the carbon nano-dots of the present invention, wherein the smaller insertion map is prediction [curcumin + H] + isotope pattern; FIG. 12A is 10 7 cells were seeded in HepG2 tumors in mice dorsal formed, respectively, and at 7 and 14 days, the carbon nano dot 220μg (440 μg in total) was injected into the tumor, the arrow pointed to the location of the injection; Figure 12B shows the diameter measurement of the tumor taken on the 16th day after inoculation of HepG2, and the left half shows the control of the uninjected carbon nanopore Group, the right half is the experimental group with the injected carbon nano-dots; and Figure 12C is the tumor taken on the 16th day after the inoculation of HepG2 Tumor weighing result of the histogram.

請參閱1所繪示,本發明提供一種碳奈米點的製造方法,至少包括如下步驟:步驟S101:提供一薑汁,是以一預定溫度對薑汁加熱一預定時間,以使薑汁碳化,並形成含有碳化物的碳奈米材料,其中較佳地,上述之預定溫度可為攝氏300度,上述之預定時間可為120分鐘,在本次示範中為利用鍛燒爐以執行上述的加熱步驟。 Referring to FIG. 1 , the present invention provides a method for manufacturing a carbon nano point, comprising at least the following steps: Step S101: providing a ginger juice, heating the ginger juice at a predetermined temperature for a predetermined time to carbonize the ginger juice. And forming a carbon nanomaterial containing carbide, wherein preferably, the predetermined temperature may be 300 degrees Celsius, and the predetermined time may be 120 minutes. In this demonstration, a calciner is used to perform the above-mentioned Heating step.

步驟S103:對該含有碳化物的碳奈米材料進行離心以取得上清液,離心的條件可為12000g、10分鐘,以去除鍛燒後所產生較大的殘渣顆粒。 Step S103: The carbide-containing carbon nanomaterial is centrifuged to obtain a supernatant, and the condition of centrifugation may be 12000 g for 10 minutes to remove large residue particles generated after calcination.

步驟S105:可以孔徑0.1微米(μm)至0.22微米的過濾膜過濾上清液,之後再對過濾後的上清液進行透析,從而製成一碳奈米點懸浮溶液,其中透析的條件及詳細的透析方式為將經過濾的上清液收集至透析管中(為了盡可能地提高透析後上清液中所含有碳奈米點及其所結合的薑黃素的比例,透析管所使用的透析膜,其較佳的分子量限值(molecule weight cut-off,MWCO)可為3.5-5kD,Float-A-Lyzer G2,光譜實驗室,牧場多明格斯,加利福尼亞州,美國),並讓整個裝有薑汁上清液的透析管置於約2公升的超純水(超純水定義:一般指經離子交換樹脂、活性碳、濾膜法去除水中主要不純物質,而使其在攝氏25度時的電阻值為18.2百萬歐姆公分)中進行為時兩小時的透析(每隔半小時更換一次超純水),以取得上述之碳奈米點懸浮溶液。接著可再對碳奈米點懸浮溶液進行為時約24小時的冷凍乾燥,可取得碳奈米點約11.1毫克。 Step S105: The supernatant can be filtered by a filter membrane having a pore size of 0.1 micrometer (μm) to 0.22 micrometer, and then the filtered supernatant is dialyzed to prepare a carbon nano point suspension solution, wherein the dialysis conditions and details are as follows. The dialysis method is to collect the filtered supernatant into the dialysis tube (in order to increase the ratio of the carbon nano-dots contained in the supernatant after dialysis and the amount of curcumin it is combined, the dialysis used in the dialysis tube) Membrane, its preferred molecular weight cut-off (MWCO) can be 3.5-5kD, Float-A-Lyzer G2, Spectral Laboratory, Rancho Dominguez, California, USA), and let the whole The dialysis tube containing the ginger juice supernatant is placed in an ultrapure water of about 2 liters (Ultra-pure water definition: generally refers to the removal of the main impurities in the water by ion exchange resin, activated carbon, and membrane method, so that it is at 25 ° C The resistance value at a time of 18.2 million ohms * cm was carried out for two hours of dialysis (replacement of ultrapure water every half hour) to obtain the above-mentioned carbon nano point suspension solution. The carbon nano point suspension solution can then be freeze-dried for about 24 hours to obtain a carbon nano point of about 11.1 mg.

請參閱圖2A中的較大圖所示,為碳奈米點之穿透式電子顯微鏡影像之觀察結果,關於碳奈米點的粒徑之大小為利用穿透式電子顯微鏡(TEM,型號:H7100,日立高新技術株式會社,東京, 日本)以進行測定。進行測定前是將所製造的碳奈米點(11.1毫克/毫升)進行10倍稀釋,再將稀釋後的碳奈米點沉積在已塗覆有400-mesh(網格)碳粒的銅網上,待沉積完成後再將多餘的溶劑烘乾。以進行碳奈米點粒徑大小之觀察。由圖2A的較大圖可知,所取得之碳奈米點懸浮溶液的碳奈米點是呈球形、且均勻地分散於溶液之中,碳奈米點的直徑(粒徑)約為3奈米至8奈米,可進一步再由圖2A中所插入的較小圖之高解析度穿透式電子顯微鏡所觀察的晶格結構(間距d為0.34奈米)之結果,再對照圖3A之碳奈米點的X光繞射結果,其在繞射角度約23.5度附近的波峰顯示碳奈米點為002平面(002 plane),與過去文獻的結果是相吻合的。 Please refer to the larger graph in Fig. 2A for the observation of the transmission electron microscope image of the carbon nano-dots. The particle size of the carbon nano-dots is determined by a transmission electron microscope (TEM, model: H7100, Hitachi High-Tech Co., Ltd., Tokyo, Japan) to carry out the measurement. Before the measurement, the manufactured carbon nano-dots (11.1 mg/ml) were diluted 10-fold, and the diluted carbon nano-dots were deposited on a copper mesh coated with 400-mesh carbon particles. On the top, the excess solvent is dried after the deposition is completed. For the observation of the particle size of the carbon nano point. As can be seen from the larger graph of FIG. 2A, the carbon nano point of the obtained carbon nano point suspension solution is spherical and uniformly dispersed in the solution, and the diameter (particle diameter) of the carbon nano point is about 3 From the rice to 8 nm, the result of the lattice structure (pitch d is 0.34 nm) observed by the high-resolution transmission electron microscope of the smaller image inserted in Fig. 2A can be further compared with Fig. 3A. As a result of the X-ray diffraction of the carbon nano-point, the peak near the diffraction angle of about 23.5 degrees shows that the carbon nano-point is the 002 plane (002 plane), which is consistent with the results of the past literature.

請再參閱圖2B所示,其為碳奈米點在激發波長325奈米至445奈米之間的螢光放光光譜,是利用Cary Eclipse的螢光光譜儀(瓦里安,加利福尼亞州,美國),來測定所製造的碳奈米點的螢光放光強度。圖2B的橫軸為給予碳奈米點的激發光的波長,簡稱激發波長,以奈米為單位,顯示碳奈米點具有可被光子激發而放出螢光的放光特性,在325奈米至445奈米的激發波長範圍下,碳奈米點可產生藍色至綠色的螢光,而在激發波長為325奈米的光照下,碳奈米點顯示出最強的螢光放光強度。並且隨著激發波長的增加,碳奈米點所放出之螢光的波長會逐漸漂移至長波長的波段,且逐漸減弱其螢光強度。故可由以上電子顯微鏡的觀察及螢光放光特性之相關定性分析結果,其在粒徑大小的範圍及螢光放光特性的結果,證明本發明之方法確實可以薑為原料而製造碳奈米點。另外,所製造的碳奈米點的量子產率Q是以如下公式進行計算:Q=QR(I/IR)(ODR/OD)(n2/n2 R),是利用Cary Eclipse的螢光光譜儀測量並計算,首先以硫酸奎寧作為參考基準,其中QR是硫酸奎寧(quinine sulphate)經由查表所得到的量子產率基準值:=0.54以做為參考基準,而將0.54帶入QR,為了對應QR=0.54之值,硫酸奎寧在波長365奈米光照下之吸收度(optical density,ODR) 可為0.1以下[此時硫酸奎寧溶於0.1M的硫酸,且硫酸奎寧的nR(折射係數)值為1.33],將以上0.54、1.33、0.1分別帶入上述公式中的QR、nR、ODR,而IR及I分別為硫酸奎寧及碳奈米點的螢光放光的積分面積/或稱積分強度,可由Cary Eclipse螢光光譜儀於365奈米波長光的激發下進行量測及利用Origin 6.0軟體執行積分計算得知。另外利用UV-Vis吸收光譜儀,量測碳奈米點在365奈米波長的OD值,其n值可由文獻查表得知,最後所求得碳奈米點的量子產率Q約為0.134(13.4%)。 Please refer to FIG. 2B again, which is a fluorescence emission spectrum of a carbon nanometer at an excitation wavelength of 325 nm to 445 nm, which is a fluorescence spectrometer using Cary Eclipse (Varian, California, USA). ), the fluorescence intensity of the produced carbon nano-dots was measured. The horizontal axis of Fig. 2B is the wavelength of the excitation light given to the carbon nano-dots, referred to as the excitation wavelength, in nanometers, showing that the carbon nano-dots have a light-emitting property that can be excited by photons to emit fluorescence, at 325 nm. At the excitation wavelength range of 445 nm, the carbon nano-dots produce blue to green fluorescence, while at an excitation wavelength of 325 nm, the carbon nano-dots exhibit the strongest fluorescence intensity. And as the excitation wavelength increases, the wavelength of the fluorescent light emitted by the carbon nano-point will gradually drift to the long-wavelength band, and gradually reduce its fluorescence intensity. Therefore, the results of the above-mentioned electron microscope observation and the qualitative analysis of the fluorescence emission characteristics, the results of the particle size range and the fluorescence emission characteristics, prove that the method of the present invention can be used as a raw material for the production of carbon nanotubes. point. In addition, the quantum yield Q of the manufactured carbon nano-dots is calculated by the following formula: Q = Q R (I / I R ) (OD R / OD) (n 2 / n 2 R ), using Cary Eclipse The fluorescence spectrometer measures and calculates, firstly, quinine sulfate as a reference, wherein Q R is the quantum yield reference value obtained by looking up the quinine sulphate: = 0.54 as a reference to the reference, and 0.54 into Q R, Q R = corresponds to the value 0.54, quinine sulfate absorbance (optical density, OD R) light at a wavelength of 365 nm can be 0.1 or less [ At this time, quinine sulfate is dissolved in 0.1M sulfuric acid, and the n R (refractive index) value of quinine sulfate is 1.33], and the above 0.54, 1.33, and 0.1 are respectively brought into Q R , n R , OD R in the above formula. And I R and I are respectively the integral area/integral intensity of the fluorescence of quinine sulfate and carbon nano-dots, which can be measured and utilized by Cary Eclipse fluorescence spectrometer under the excitation of 365 nm wavelength light. Origin 6.0 software performs integral calculations. In addition, the UV-Vis absorption spectrometer was used to measure the OD value of the carbon nano-dots at a wavelength of 365 nm. The n value can be found from the literature. Finally, the quantum yield Q of the carbon nano-point is about 0.134 ( 13.4%).

請再參閱圖2C所示,其為利用傅立葉轉紅外光譜儀以偵測本發明之碳奈米點上所存在的官能基團的圖譜,是利用紫外可見光譜儀(Cintra 10e,丹德農,維多利亞州,澳大利亞)來測量碳奈米點之吸收。該圖的橫軸所表示的為所使用紅外光的波數(wavenumber),單位為cm-1,紅外光的波數可被視為相當於紅外光的頻率;該圖的縱軸所表示的為穿透率(transmittance),單位為%,換言之,當穿透率下降時代表碳奈米點在該紅外光波數/頻率下會吸收該紅外光。由圖譜可知本發明碳奈米點的表面具有:O-H/N-H(3400cm-1)、C-H(3000cm-1)、C=O(1700cm-1)、C-O(1100cm-1)、以及CH2(1400cm-1)等基團。另外,還可由所測得之Zeta電位值(約-35mV),證實碳奈米點表面確實存在的-OH基團及-COOH基團等親水性基團,因此進一步言之,本發明之碳奈米點的表面可具有該些親水性基團,可有助於本發明之碳奈米點在一般水性溶液之載體中維持良好的分散性,有助於避免碳奈米點之間聚集成較大的粒子,以至於失去奈米化的特性,奈米化的特性也有助於碳奈米點在生物方面的應用。 Please refer to FIG. 2C again, which is a map using a Fourier transform infrared spectrometer to detect the functional groups present on the carbon nano-dots of the present invention, using an ultraviolet-visible spectrometer (Cintra 10e, Dandenong, Victoria). , Australia) to measure the absorption of carbon nano-dots. The horizontal axis of the graph indicates the wavenumber of the infrared light used, and the unit is cm -1 . The wave number of the infrared light can be regarded as the frequency corresponding to the infrared light; the vertical axis of the figure indicates For transmittance, the unit is %, in other words, when the transmittance decreases, the carbon nano-dots absorb the infrared light at the infrared wave number/frequency. It can be seen from the map that the surface of the carbon nano-dots of the present invention has: OH/NH (3400 cm -1 ), CH (3000 cm -1 ), C=O (1700 cm -1 ), CO (1100 cm -1 ), and CH 2 (1400 cm). -1 ) and other groups. In addition, the measured zeta potential value (about -35 mV) can also confirm the hydrophilic groups such as the -OH group and the -COOH group which are indeed present on the surface of the carbon nano-point, and therefore, further, the carbon of the present invention The surface of the nano-dots may have such hydrophilic groups, which may contribute to maintaining good dispersibility of the carbon nano-dots of the present invention in a carrier of a general aqueous solution, and help to avoid aggregation between carbon nano-dots. Larger particles, so that they lose the characteristics of nanocrystallization, the characteristics of nanocrystallization also contribute to the biological application of carbon nano points.

請繼續參閱圖2D,其為利用X光光譜儀對碳奈米點所測得之四種束縛能的結果,是使用Varian 640 FT-IR光譜儀(瓦里安公司,美國)來分析可能存在碳奈米點的官能團。在該圖中的橫軸所表示的為碳原子與其他原子鍵結時的束縛能,單位為電子伏特 (eV);縱軸為所使用的X光光電子的強度/計數(intensity/counts)。其中碳(C)、氧(O)和氮(N)的比例分別為0.72、0.17及0.11。另外,請再配合圖4A的碳的1s的X光光電子能譜儀之結果,其中顯示本發明之碳奈米點具有四個主要的束縛能:284.7、286.5、287.3以及288.5電子伏特,其分別對應到的碳的鍵結形式如下:C=C/C-C、C-O、C=O以及C-NHxPlease continue to refer to Figure 2D, which is the result of using the X-ray spectrometer to measure the four binding energies of the carbon nanotubes. The Varian 640 FT-IR spectrometer (Varian, USA) was used to analyze the possible presence of carbon naphthalene. Functional group of rice dots. The horizontal axis in the figure indicates the binding energy when the carbon atoms are bonded to other atoms, and the unit is electron volt (eV); and the vertical axis indicates the intensity/counts of the X-ray photoelectrons used. The ratios of carbon (C), oxygen (O) and nitrogen (N) are 0.72, 0.17 and 0.11, respectively. In addition, please cooperate with the results of the 1s X-ray photoelectron spectrometer of carbon of Figure 4A, which shows that the carbon nano-dots of the present invention have four main binding energies: 284.7, 286.5, 287.3, and 288.5 eV, respectively. The bonded form of the corresponding carbon is as follows: C=C/CC, CO, C=O, and C-NH x .

請再接著參閱圖4B所示,其為碳奈米點的拉曼(Raman)光譜之結果圖,該圖的橫軸所表示的為拉曼位移(Raman shift),單位為波數(cm-1);縱軸為強度(intensity),單位為任意單位(arbitrary unit,a.u.),其中在頻率1337cm-1和1562cm-1的位置處,分別有代表SP3混成(SP3-hybridized)的D條帶(band)和代表SP2混成(SP2-hybridized)的G條帶之存在,其中D條帶代表的是碳原子的結晶缺陷程度;G條帶代表的是碳原子的結晶化程度,由D條帶與G條帶兩者間相對強渡的比值(ID/IG=1.20)得知,本發明之碳奈米點的結構類似於石墨烯。 Please refer to FIG. 4B again, which is a result of the Raman spectrum of the carbon nano-point, and the horizontal axis of the figure represents the Raman shift, and the unit is the wave number (cm - 1); the vertical axis represents intensity (intensity), an arbitrary unit (arbitrary unit, au), at a position where the frequency of 1337cm -1 and 1562cm -1, respectively, on behalf of SP 3 hybrid (SP 3 -hybridized) of D band (band) representing SP 2 hybrid (SP 2 -hybridized) present in the G band, where D represents the strip crystal defect level carbon atoms; G band represents the degree of crystallization carbon atoms, From the ratio of the relatively strong cross between the D strip and the G strip (ID/IG = 1.20), it is known that the carbon nanopoint of the present invention has a structure similar to graphene.

請參閱圖4C所示,其為碳奈米點進行13C NMR分析後之光譜圖,是利用13C NMR光譜(AVIII-500 MHz FT-NMR,布魯克公司,賴因斯特滕市,德國),以量測碳奈米點的碳混成(carbon hybridization)的形式。碳奈米點在經由NMR分析之後可瞭解到,在8-80ppm與90-180ppm的區間分別代表脂肪族(aliphatic)碳原子(SP3混成,SP3-hybridized)及不飽和的(SP2混成,SP2-hybridized)。此外,170-185ppm的區間的訊號則多代表著羧基(-COOH)或醯胺基團(amine group)的存在。 Please refer to Figure 4C, which is a spectrum of 13 C NMR analysis of the carbon nano-dots using 13 C NMR spectroscopy (AVIII-500 MHz FT-NMR, Bruker, Reinstetten, Germany) To measure the form of carbon hybridization of carbon nano-dots. Carbon nano dot may be learned by NMR analysis after, in the range 90-180ppm of 8-80ppm represent aliphatic (Aliphatic) carbon atoms (SP 3 hybrid, SP 3 -hybridized) and unsaturated (SP 2 hybrid , SP 2 -hybridized). In addition, the signal in the interval of 170-185 ppm mostly represents the presence of a carboxyl group (-COOH) or an amine group.

請參閱圖5A、圖5B及圖5C所示,分別是碳奈米點在不同的pH值、氯化鈉濃度及照光時間下的螢光強度測試之結果,如圖5A所示,將碳奈米點配置在5mM且pH值為3.0至11.0的磷酸鹽緩衝溶液(phosphate buffers)中,發現經由本發明之方法所製造的碳奈米點可在pH 3.0至pH 10.0之間還維持著其螢光強度的穩定 性。而如圖5B所示,將碳奈米點配置於含有0至500mM氯化鈉的磷酸鹽緩衝溶液(磷酸鹽濃度5mM,pH值7.4)中,可以了解到本發明的碳奈米點無論在低鹽或高鹽的環境之下,仍可保持穩定的螢光放光特性。又如圖5C所示,將碳奈米點配置於5mM、pH值7.4的磷酸鹽溶液中,並以每平方公分的功率達6瓦特(6W/cm2)的紫外光連續照射碳奈米點達6小時,並搭配Cary Eclipse的螢光光譜儀來測定碳奈米點的螢光放光強度的穩定性,可發現經過六小時的紫外光的照射後,碳奈米點的螢光放光強度僅有些微的減弱(約減弱8%),顯示本發明之碳奈米點可耐受不同pH的變化、適應高低鹽的環境以及具有可承受光罩的高穩定性。 Please refer to FIG. 5A, FIG. 5B and FIG. 5C, which are the results of the fluorescence intensity test of the carbon nano point at different pH values, sodium chloride concentration and illumination time, respectively, as shown in FIG. 5A. The rice dots were placed in 5 mM phosphate buffers with a pH of 3.0 to 11.0. It was found that the carbon nanotubes produced by the method of the present invention maintained their fluorescing between pH 3.0 and pH 10.0. Stability of light intensity. As shown in FIG. 5B, the carbon nano point is disposed in a phosphate buffer solution (phosphate concentration: 5 mM, pH 7.4) containing 0 to 500 mM sodium chloride, and it can be understood that the carbon nano point of the present invention is Stable fluorescence emission characteristics are maintained in low salt or high salt environments. As shown in Fig. 5C, the carbon nano-dots were placed in a 5 mM phosphate solution having a pH of 7.4, and the carbon nano-dots were continuously irradiated with ultraviolet light of 6 watts (6 W/cm 2 ) per square centimeter. Up to 6 hours, and with the Cary Eclipse fluorescence spectrometer to determine the stability of the fluorescence intensity of the carbon nano-point, you can find the fluorescence intensity of the carbon nano-dots after six hours of ultraviolet light irradiation. Only a slight weakening (about 8% reduction) shows that the carbon nano-dots of the present invention can withstand different pH changes, adapt to high and low salt environments, and have high stability to withstand reticle.

請參閱圖6所示,其為碳奈米點在五種細胞株之中的明視野(A)及螢光影像(B)之結果圖,其中所使用的五種細胞株分別為:正常細胞(MCF-10A)和腫瘤細胞(A594、MDA-MB-231、HeLa以及HepG2),主要來自於美國典型培養物保藏中心(馬納薩斯,弗吉尼亞州,美國)。A549,HeLa,HepG2和MDA-MB-231培養在含有10%胎牛血清、1%抗生素-抗真菌劑、2mM L-谷氨酰胺和1%非必需氨基酸的DMEM培養液中,並讓細胞於空氣組成具有佔容積5%的二氧化碳、攝氏37度的環境下(細胞培養箱)培養。MCF10A培養於含有10%胎牛血清及1%抗生素-抗真菌劑的α-MEM培養液,且同樣置於5% CO2、攝氏37的環境下培養,在進行細胞毒性測試前,將細胞的密度控制在400個細胞/100微升/培養井孔(cells/100μL/well),且分別種在96孔盤中。進行細胞毒性實驗後,再以1X PBS(phosphate buffer saline,含有0.027M KCl、0.14M NaCl、1.76mM KH2PO4和0.01M Na2HPO4,且pH為7.4)緩衝溶液進行三次清洗。即可接著將上述五種細胞分別與1.11.毫克/毫升的碳奈米點進行4小時的反應,再進行觀察與影像的紀錄,在進行細胞觀察之前還先以4%的多聚甲醛固定細胞15分鐘,之後再以1倍濃度的PBS緩衝溶液清洗,再進行光學和螢光顯微鏡 的觀察。所使用的影像系統為Olympus BX61(東京,日本)之顯微鏡搭配DP71數位相機以觀察並紀錄細胞胞吞碳奈米點之影像。可發現,除了明視野影像外,當分別以(a)紫外光(波長為360-380奈米)、(b)藍光(波長為460-480奈米)以及(c)綠光(波長為510-530奈米)激發時,可分別清楚看到藍色、綠色與紅色的細胞影像。而且由圖6可發現,大多數的碳奈米點是位於細胞的胞質區。 Please refer to FIG. 6 , which is a result of the bright field (A) and the fluorescent image (B) of the carbon nano-points among the five cell lines, wherein the five cell lines used are: normal cells. (MCF-10A) and tumor cells (A594, MDA-MB-231, HeLa, and HepG2), mainly from the American Type Culture Collection (Manassas, Virginia, USA). A549, HeLa, HepG2 and MDA-MB-231 were cultured in DMEM containing 10% fetal bovine serum, 1% antibiotic-antimycotic, 2mM L-glutamine and 1% non-essential amino acids, and let the cells The air composition was cultured in an environment of 5% by volume of carbon dioxide and 37 degrees Celsius (cell culture incubator). MCF10A was cultured in α-MEM containing 10% fetal bovine serum and 1% antibiotic-antimycotic, and was also cultured in 5% CO 2 and 37 ° C. Before cytotoxicity test, cells were The density was controlled at 400 cells/100 microliters/culture wellbore (cells/100 μL/well) and seeded in 96-well plates, respectively. After the cytotoxicity test, the washing was performed three times with a buffer solution of 1X PBS (phosphate buffer saline containing 0.027 M KCl, 0.14 M NaCl, 1.76 mM KH 2 PO 4 and 0.01 M Na 2 HPO 4 , and pH 7.4). The above five cells can then be reacted with 1.11 mg/ml of carbon nano-dots for 4 hours, and then observed and imaged. The cells are fixed with 4% paraformaldehyde before cell observation. After 15 minutes, it was washed with a 1x concentration of PBS buffer solution and observed by optical and fluorescence microscopy. The imaging system used was an Olympus BX61 (Tokyo, Japan) microscope with a DP71 digital camera to observe and record images of cell endocytosed carbon nano-dots. It can be found that, in addition to the bright field image, (a) ultraviolet light (wavelength of 360-380 nm), (b) blue light (wavelength of 460-480 nm), and (c) green light (wavelength of 510) -530 nm) When excited, the cell images of blue, green and red can be clearly seen separately. Moreover, as can be seen from Figure 6, most of the carbon nano-dots are located in the cytoplasmic region of the cell.

請參閱圖7A所示,其為碳奈米點對細胞的毒性測試結果。主要是利用Alamar Blue[Alamar Blue試劑自Biosource(卡馬里奧,加利福尼亞州,美國)購得]來分析細胞的存活率,分別將上述五種細胞養於細胞培養孔盤(well)中,每個孔盤中的初始細胞濃度約4000cells/100μL(細胞/100微升),並於5%的二氧化碳、攝氏37度的環境下培養24小時後,接著以濃度為0、0.18、0.35、0.7、1.4、2.8毫克/毫升(mg/ml)的碳奈米點分別加至上述的五種細胞的培養孔盤中,待再培養24小時後,再以1倍濃度的PBS溶液進行三次的清洗,接著以培養液將Alamar Blue試劑進行原濃度的10倍稀釋,並分別將含有Alamar Blue的100微升培養液加至培養細胞用的孔盤中以作用4小時,再利用微量盤式螢光光譜儀[Synergy,購自BioTek公司(威努斯基,佛蒙特州,美國)]以偵測細胞的存活率(激發波長為545奈米,螢光放光波長為590奈米)。一般而言,與細胞反應過後的Alamar Blue的螢光強度與活細胞成正比,因此可用來計數細胞的存活率。如圖7A所示,橫軸所表示的為所加入的碳奈米點濃度;縱軸所表示的為各細胞的存活率。以上五種細胞經過上述不同濃度的碳奈米點濃度的作用後,顯示,HepG2細胞會隨著碳奈米點濃度的增加,而呈現出明顯遞減的存活率;而對於其他正常細胞(MCF-10A)和腫瘤細胞(A549和HeLa),生長情形仍維持穩定,顯示碳奈米點對正常細胞跟腫瘤細胞A549及HeLa具有較少的細胞毒性。而當碳奈米點的濃度增加到1.4毫克/毫升時,則開始對腫瘤細胞MDA-MB-231造成相對明 顯的細胞毒性。因此由以上圖7A所示,可推算出,碳奈米點對HepG2的50%抑制生長濃度(concentration of 50% inhibition,IC50)為0.32毫克/毫升至0.38毫克/毫升(可抑制50%的HepG2細胞的存活的濃度),而在碳奈米點濃度達1.4毫克/毫升時除了HepG2細胞之外的其他細胞均仍有80%以上的細胞存活率,顯示本發明之碳奈米點除了對HepG2有較為專一的抑制效果之外,相對於其他細胞而言也具有較低的細胞毒性。 Please refer to FIG. 7A, which is a result of toxicity test of carbon nano dots to cells. The survival rate of the cells was mainly analyzed by using Alamar Blue [Alamar Blue reagent purchased from Biosource (Camarillo, Calif., USA)], and the above five cells were respectively cultured in a cell culture well, each The initial cell concentration in the well plate was about 4000 cells/100 μL (cells/100 μl), and cultured for 24 hours under 5% carbon dioxide and 37 degrees Celsius, followed by concentrations of 0, 0.18, 0.35, 0.7, 1.4. The carbon nano-dots of 2.8 mg/ml (mg/ml) were added to the culture wells of the above five kinds of cells, and after being cultured for another 24 hours, they were washed three times with the PBS solution of 1 time, and then The Alamar Blue reagent was diluted 10 times in the original concentration with the culture solution, and 100 μl of the culture solution containing Alamar Blue was separately added to the well plate for the cultured cells for 4 hours, and then the microplate type fluorescence spectrometer was used. Synergy, purchased from BioTek (Wenuschi, Vermont, USA), was used to detect cell viability (excitation wavelength 545 nm, fluorescence emission wavelength 590 nm). In general, the fluorescence intensity of Alamar Blue after reaction with cells is proportional to living cells and can therefore be used to count cell viability. As shown in Fig. 7A, the horizontal axis represents the concentration of the carbon nanotubes added; and the vertical axis represents the survival rate of each cell. After the above five kinds of cells were subjected to the above-mentioned different concentrations of carbon nano-dots, it showed that HepG2 cells showed a significantly decreasing survival rate with the increase of the carbon nano-dots concentration; and for other normal cells (MCF- 10A) and tumor cells (A549 and HeLa), the growth condition remained stable, indicating that the carbon nano-dots have less cytotoxicity to normal cells and tumor cells A549 and HeLa. When the concentration of carbon nano-dots increased to 1.4 mg / ml, it began to cause relatively bright tumor cells MDA-MB-231 Significant cytotoxicity. Therefore, as shown in FIG. 7A above, it can be inferred that the 50% inhibition concentration (IC50) of the carbon nanoparticle to HepG2 is 0.32 mg/ml to 0.38 mg/ml (the HepG2 can be inhibited by 50%). The concentration of cells survived, and at the carbon nano spot concentration of 1.4 mg/ml, cells other than HepG2 cells still had more than 80% cell viability, indicating that the carbon nano-dots of the present invention were in addition to HepG2. In addition to a more specific inhibitory effect, it also has lower cytotoxicity than other cells.

另外請再對照圖7B,其為上述五種細胞株在加入濃度為2.8毫克/毫升的碳奈米點作用24小時的p53蛋白的表現情形之結果,是以西方墨點法(Western blot)呈現該結果,西方墨點的執行為分別將上述細胞破碎後,以10%聚丙烯醯胺膠體電泳法(SDS/PAGE)將蛋白質進行電泳分離,接著為解析的蛋白質在電場中的位移,將膠體轉移到polyvinylidene difluoride(PVDF)膜上,並在含有1倍Tris-buffered saline(TBS)、0.1% Tween 20、5%重量/體積的脫脂奶粉的阻絕緩衝液(blocking buffer)下反應1小時。接著將膜浸於4℃的環境下,分別與一級抗體:anti-p53[來自Santa Cruz生物科技(Santa Cruz,CA)]及anti-α-tubulin抗體[來自Oncogene Science(劍橋,馬薩諸塞州)]反應overnight。所有的一級抗體皆稀釋在1X Tris-buffered saline(TBS;25mM Tris,150mM NaCl,2mM KCl,pH 7.4)含有0.1% Tween 20 with 5% w/v BSA中。將PVDF膜充分洗滌後,將其置於horseradish peroxidase(HRP)-conjugated goat anti-rabbit immunoglobulin G抗體中(1:2000稀釋,Rockland Immunochemicals,Gilbertsville,PA),於室溫下反應1小時。由西方墨點的數據可發現在有加入碳奈米點的情況,相對於未加入碳奈米點的情況,HepG2的p53蛋白質的表現量確實有相對顯著的提升。 In addition, please refer to FIG. 7B, which is the result of the performance of the above five cell lines on the addition of p53 protein at a concentration of 2.8 mg/ml for 24 hours, which is represented by Western blot. As a result, the western ink dot is executed by separately breaking the above-mentioned cells, and electrophoresis is carried out by 10% polypropylene guanamine colloid electrophoresis (SDS/PAGE), followed by dissociation of the resolved protein in the electric field, and colloid Transfer to a polyvinylidene difluoride (PVDF) membrane and react for 1 hour in a blocking buffer containing 1x Tris-buffered saline (TBS), 0.1% Tween 20, 5% w/v skim milk powder. The membrane was then immersed in a 4 ° C environment with primary antibody: anti-p53 [from Santa Cruz Biotechnology (Santa Cruz, CA)] and anti-α-tubulin antibody [from Oncogene Science (Cambridge, MA)] Reaction overnight. All primary antibodies were diluted in 1X Tris-buffered saline (TBS; 25 mM Tris, 150 mM NaCl, 2 mM KCl, pH 7.4) containing 0.1% Tween 20 with 5% w/v BSA. After the PVDF membrane was sufficiently washed, it was placed in a horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G antibody (1:2000 dilution, Rockland Immunochemicals, Gilbertsville, PA), and reacted at room temperature for 1 hour. From the data of the western ink spots, it can be found that in the case where the carbon nano-dots are added, the expression level of the p53 protein of HepG2 does have a relatively significant increase relative to the case where the carbon nano-dots are not added.

而請再繼續參閱圖7C所示,其所表示的為在加有濃度1.11毫克/毫升的碳奈米點,並在作用24小時後的HepG2細胞的細胞 週期分布,在圖7C的左圖為未添加碳奈米點的HepG2細胞(控制組);圖7C的右圖為有添加碳奈米點的HepG2細胞的實驗組,由數據顯示,未添加碳奈米點的HepG2細胞,其SubG1 fraction僅有7.4%,而當添加碳奈米點後,如圖7C的右圖的實驗組所示,HepG2細胞中處於細胞週期的SubG1時期的比例便提高至43.1%。另外可由圖7C的數據了解到,在碳奈米點存在的情況下,HepG2細胞處於細胞週期G0/G1與G2/M兩時期的比例均有顯著的下降,然而SubG1的比例卻上升,意味著碳奈米點能夠誘導HepG2走向細胞凋亡的途徑。 Please continue to refer to Figure 7C, which shows the cells of HepG2 cells after the addition of a carbon nanoparticle concentration of 1.11 mg/ml and after 24 hours of action. The periodic distribution, in the left panel of Fig. 7C, is the HepG2 cells (control group) to which no carbon nanotubes are added; the right panel of Fig. 7C is the experimental group of HepG2 cells with carbon nanotubes added, and the data shows that no carbon is added. At the nano-point HepG2 cells, the SubG1 fraction was only 7.4%, and when the carbon nano-dots were added, as shown in the experimental group on the right in Fig. 7C, the proportion of the SubG1 phase in the cell cycle in HepG2 cells was increased to 43.1%. In addition, it can be understood from the data in Fig. 7C that in the presence of carbon nano-dots, the ratio of HepG2 cells in the cell cycle G0/G1 and G2/M is significantly decreased, but the proportion of SubG1 is increased, meaning Carbon nanospots can induce HepG2 pathways toward apoptosis.

另外請參閱圖8所示,其為上述五種細胞株在分別加入0、1.6、3.1、6.3、12.5以及25%之重量百分濃度的新鮮薑汁,作用24小時後的存活率,其中所使用的新鮮薑汁是經過一些前處理而得,前處理的方式如下所述,提供新鮮薑汁,體積大約為20毫升,薑汁可以由一般傳統市場購得的生薑經去皮、切片、研磨後而得,接著以轉速12000g對新鮮薑汁進行10分鐘的離心以取得此新鮮薑汁的上清液。調整此新鮮薑汁的上清液的酸鹼值(pH值)至呈弱鹼性,較佳地,可透過氫氧化鈉以對此新鮮薑汁的上清液調整其pH值到7.1至7.6之間,在本次示範則選擇以pH值7.4的新鮮薑汁的上清液以進行後續的實驗。接著再次過濾此新鮮薑汁的上清液以移除多餘的固體殘渣,較佳地,還可以孔徑0.1微米至0.22微米的過濾膜以過濾此新鮮薑汁的上清液,以上作法除了可以去除第一薑汁上清液中多餘的固體殘渣之外,還可以有效去除其中有害的寄生蟲或細菌等微生物,如此即可供此實驗之用,以作為相對於本發明之碳奈米點的對照組。由圖8可發現HepG2也一樣會隨著新鮮薑汁濃度的上升而具有顯著較低的存活率,然而可發現正常細胞MCF-10A也一樣會隨著新鮮薑汁濃度的上升而具有顯著較低的存活率,而且在同樣的新鮮薑汁的濃度之下,正常細胞MCF-10A卻比HepG2之腫瘤細胞具有更低的存活率,顯示新鮮薑 汁較容易為正常細胞帶來毒性,而本發明之碳奈米點卻不會有此缺點,顯然,本發明之碳奈米點相較於一般新鮮薑汁而言,對HepG2細胞具有較為專一的選擇性抑制效果,且較不會對其他正常細胞造成不利的毒性。 In addition, please refer to FIG. 8 , which is the survival rate of the above five cell strains after adding fresh ginger juice of 0, 1.6, 3.1, 6.3, 12.5 and 25% by weight respectively, after 24 hours, wherein The fresh ginger juice used is obtained by some pretreatment. The pretreatment method is as follows. Fresh ginger juice is provided in a volume of about 20 ml. The ginger juice can be peeled and sliced from ginger which is generally purchased in the market. After grinding, fresh ginger juice was centrifuged at 12,000 g for 10 minutes to obtain a supernatant of the fresh ginger juice. Adjusting the pH value (pH) of the supernatant of the fresh ginger juice to be weakly alkaline. Preferably, the pH of the fresh ginger juice is adjusted to 7.1 to 7.6 by NaOH. In the present demonstration, the supernatant of fresh ginger juice at pH 7.4 was selected for subsequent experiments. The supernatant of the fresh ginger juice is then filtered again to remove excess solid residue. Preferably, the filter membrane having a pore size of 0.1 μm to 0.22 μm can also be used to filter the supernatant of the fresh ginger juice, which can be removed by the above method. In addition to the excess solid residue in the first ginger juice supernatant, microorganisms such as harmful parasites or bacteria can be effectively removed, so that it can be used for the experiment as a carbon nanopore relative to the present invention. Control group. It can be seen from Fig. 8 that HepG2 also has a significantly lower survival rate as the concentration of fresh ginger juice increases. However, it can be found that normal cell MCF-10A also has a significantly lower level with the increase of fresh ginger juice concentration. Survival rate, and under the same fresh ginger juice concentration, normal cell MCF-10A has a lower survival rate than HepG2 tumor cells, showing fresh ginger Juice is more likely to bring toxicity to normal cells, but the carbon nano-dots of the present invention do not have this disadvantage. Obviously, the carbon nano-dots of the present invention are more specific to HepG2 cells than ordinary fresh ginger juice. The selective inhibition effect is less harmful to other normal cells.

另外,本發明之碳奈米點是由薑所製造而成,換言之,本發明是一種以天然物的薑作為碳源的碳奈米點,可對HepG2之肝癌細胞具有較佳的選擇性的抑制效果,如圖9所示,一些非以薑作為碳源的碳奈米點,如由綠茶、甘胺酸及EDTA所製造的碳奈米點,對HepG2的抑制效果也都欠佳,例如,同樣均在2.8毫克/毫升的濃度下,上述非以薑作為碳源的碳奈米點對HepG2的抑制效果最佳只能到達約40%的細胞存活率的抑制效果(綠茶),而其他如甘胺酸及EDTA在相同碳奈米點濃度下,HepG2都還分別具有80%及60%的存活率。然而如以本發明以薑作為碳源的碳奈米點而言,在2.8毫克/毫升的濃度下即可使HepG2細胞的存活率達到約5%-10%(圖7A),顯示本發明之以薑作為碳源的碳奈米點確實較其他非以薑作為碳源的碳奈米點而言具有意想不到的HepG2細胞的抑制生長效果。 In addition, the carbon nano-dots of the present invention are manufactured by ginger, in other words, the present invention is a carbon nano-powder using natural ginger as a carbon source, and has a better selectivity for hepatoma cells of HepG2. The inhibitory effect, as shown in Fig. 9, some carbon nano-dots not using ginger as a carbon source, such as carbon nano-dots made of green tea, glycine and EDTA, have a poor inhibitory effect on HepG2, for example, At the same concentration of 2.8 mg / ml, the above-mentioned carbon nano-dots with non-ginger as a carbon source have the best inhibitory effect on HepG2, which can only achieve about 40% inhibition of cell viability (green tea), while others For example, glycine and EDTA have a survival rate of 80% and 60%, respectively, at the same carbon nano point concentration. However, in the case of the carbon nano point of the present invention using ginger as a carbon source, the survival rate of HepG2 cells can be about 5%-10% at a concentration of 2.8 mg/ml (Fig. 7A), showing the present invention. The carbon nano-points using ginger as a carbon source do have an unexpected growth-inhibiting effect on HepG2 cells compared to other carbon nano-points that do not use ginger as a carbon source.

請繼續參閱圖10所示,其為利用影像細胞儀分析上述五種細胞株對碳奈米點之胞吞效果(橫軸)及ROS(縱軸)之產生情形之結果,其中左半部(A)欄位為控制組,未添加碳奈米點;右半部(B)欄位為實驗組,有添加碳奈米點。利用DHE(dihydroethidine)染劑以偵測細胞中的超氧化物,一旦與細胞中的ROS反應後,即會生成可嵌入DNA的2-hydroxyethidium,並產生紅色螢光,以得知細胞胞吞碳奈米點後所產生的ROS,其主要的實驗方法為,上述五種細胞株分別以2×105細胞數/孔盤(cells/well)的初始細胞濃度培養在細胞培養液中,並置於含有5%容積的二氧化碳,37℃的細胞培養箱中培養24小時。之後將濃度為1.11毫克/毫升碳奈米點材料添加於各別所使用的培養液中,以便與已貼盤的細胞反應4 小時,之後再以1倍濃度的PBS溶液進行三次清洗。再將新鮮配製的體積100μl、濃度5μM的DHE分別加入細胞的培養孔盤中反應0.5個小時,之後以1倍濃度的PBS溶液進行三次清洗,再利用1倍濃度的胰蛋白酶使細胞不再附著於培養孔盤的底部,送入影像細胞儀系統進行分析((NucleoCounter NC-3000,Chemometec,Allerd,丹麥)。碳奈米點及DHE分別以365與475nm激發,藉由475與530nm的放光來得知細胞對材料的胞吞情形及其ROS的產生。故可由圖10右半部欄位得知,在添加濃度為1.11毫克/毫升的碳奈米點之後,HepG2細胞中有進行胞吞行為的比例從未添加碳奈米點的15.72%提升至有添加碳奈米點的83.79%,而且產生ROS的細胞比例也從未添加碳奈米點的0.86%提升至有添加碳奈米點的15.66%,顯示相較於未添加碳奈米點的HepG2,在添加碳奈米點後可誘導HepG2細胞內產生約18.2倍的ROS,然而對於其他細胞而言,卻無顯著的ROS的提升。又,一般而言ROS可能是誘導細胞程序性死亡、促使細胞DNA及細胞本身損傷已使細胞走向凋亡的途徑、指標之一,此外,又從圖7B知西方墨點法的結果得知,HepG2的p53可被本發明之薑源性碳奈米點誘導而表現。 Please continue to refer to FIG. 10, which is a result of analyzing the effect of the above-mentioned five cell lines on the endocytosis effect (horizontal axis) and ROS (vertical axis) of the carbon nano-points by using an image cytometer, wherein the left half ( A) The field is the control group, and the carbon nano-point is not added; the right half (B) field is the experimental group, and the carbon nano-dots are added. Use DHE (dihydroethidine) dye to detect superoxide in cells. Once reacted with ROS in cells, it will generate 2-hydroxyethidium which can be inserted into DNA and produce red fluorescence to know the cell endocytosis. The main experimental method for ROS produced after the nano-point is that the above five cell lines are cultured in a cell culture medium at an initial cell concentration of 2 × 10 5 cells/cells/well, and placed. The carbon dioxide containing 5% by volume was cultured in a cell incubator at 37 ° C for 24 hours. Thereafter, a 1.11 mg/ml carbon nanopoint material was added to each of the culture solutions used to react with the plated cells for 4 hours, and then washed three times with a 1-fold concentration of PBS solution. Then, freshly prepared 100 μl of DHE and 5 μM of DHE were added to the culture wells of the cells for 0.5 hour, then washed three times with 1 time of PBS solution, and then the cells were stopped by 1 time of trypsin. At the bottom of the culture well plate, it is sent to the image cytometry system for analysis ((NucleoCounter NC-3000, Chemometec, Aller) d, Denmark). The carbon nano-dots and DHE were excited at 365 and 475 nm, respectively. The emission of 475 and 530 nm was used to know the cell endocytosis of the material and the production of ROS. Therefore, it can be seen from the right half of the field in Figure 10. After the addition of a carbon nanoparticle concentration of 1.11 mg/ml, the proportion of endocytic behavior in HepG2 cells was increased from 15.72% of the carbon nano-dots. 83.79% of the carbon nano-dots were added, and the proportion of cells producing ROS was also increased from 0.86% of the carbon-free point to 15.66% of the added carbon nano-dots, compared to HepG2 without the carbon-doped point. After the addition of the carbon nano-dots, about 18.2 times of ROS was induced in HepG2 cells, whereas for other cells, there was no significant increase in ROS. In addition, ROS may be one of the pathways and indicators for inducing programmed cell death, causing cell DNA and cell damage to cause apoptosis, and further, from the results of the Western blot method shown in FIG. 7B, The p53 of HepG2 can be expressed by the ginger-derived carbon nanopoint of the present invention.

承上,因此顯然HepG2在添加碳奈米點後,可達到引發細胞的ROS以誘導HepG2細胞進入細胞凋亡,而在細胞的ROS上升之際,顯示細胞正經歷壓力,因此連帶地引發HepG2細胞的p53的表現,然而其他以EDTA、甘胺酸及綠茶為原料所製成的碳奈米點卻無法達到對HepG2細胞的顯著增值抑制效果。顯然本發明以薑作為碳源的碳奈米點應與其他非以薑作為碳源的碳奈米點有其不同之處。為了進一步了解碳奈米點表面是否帶有可對HepG2細胞造成增值抑制效果的特殊成分,請參閱圖11所示,其為以濃度為0.011mg/mL的碳奈米點材料的SALDI(surface-assisted laser description/ionization time-of-flight mass spectrometry)質譜圖,是 在反射器正離子模式下操作,採用脈衝雷射光照射(Nd:YAG,355nm波長,100赫茲,脈衝寬度6ns)的照射。利用13奈米的金奈米粒子(gold nanoparticles)當作基質,搭配表面輔助雷射脫附游離飛行時間質譜儀(SALDI-TOF MS;布魯克道爾頓公司,不來梅市,德國)來分析碳奈米點可能存在生物活性之成分。該儀器利用金團簇進行校正([Aux]+;x=1-5),雷射能量約為102.5W cm-2。是以7.5nM濃度之上述金奈米粒子當作基質,並在0.5mM、pH 7.0的檸檬酸銨緩衝溶液(ammonium citrate buffer)中反應。其中,質荷比(m/z):369.888,370.900以及371.889的三組數值所表示的是[薑黃素+H]+同位素;插入圖:為預測的[薑黃素+H]+同位素,為利用SALDI-TOF MS而測定。在質荷比為369.888、370.900及371.889的情況下,可對應出同位素[薑黃素+H]+之的相對波峰,表示碳奈米點盡管在經過透析之後,碳奈米點依舊可結合(或帶有/附有)薑黃素分子。換言之,本發明成功地以薑作為碳源以製造/合成碳奈米點,且其被製成後,薑黃素即可自然地與碳奈米點共存而且不會因為透析而消失的技術特點,解決了薑黃素的水溶性差而難以被製成適當的水溶性製劑,以及難以被送入細胞(如肝癌細胞、肝腫瘤細胞)的問題。 Therefore, it is clear that HepG2 can achieve cell-derived ROS to induce HepG2 cells to enter apoptosis after adding carbon nano-dots, and when the ROS of the cells rise, it shows that the cells are experiencing pressure, thus triggering HepG2 cells. The performance of p53, however, other carbon nano-dots made from EDTA, glycine and green tea could not achieve significant value-added inhibition of HepG2 cells. It is apparent that the carbon nano-dots of the present invention using ginger as a carbon source should be different from other carbon nano-dots not using ginger as a carbon source. In order to further understand whether the surface of the carbon nano-point has a special component that can exert a value-adding inhibitory effect on HepG2 cells, please refer to FIG. 11 , which is a SALDI (surface- at a concentration of 0.011 mg/mL of carbon nano point material. Assisted laser description/ionization time-of-flight mass spectrometry) is a spectrometer that operates in a reflector positive ion mode with pulsed laser light (Nd:YAG, 355 nm wavelength, 100 Hz, pulse width 6 ns). Analysis of carbon naphthalene using 13 nm gold nanoparticles as matrix and surface assisted laser desorption free time-of-flight mass spectrometer (SALDI-TOF MS; Brooke Dalton, Bremen, Germany) Rice spots may have biologically active ingredients. The instrument is calibrated using gold clusters ([Au x ] + ; x = 1-5) and the laser energy is approximately 102.5 W cm -2 . The above-mentioned gold nanoparticles having a concentration of 7.5 nM were used as a substrate, and reacted in an ammonium citrate buffer of 0.5 mM and pH 7.0. Among them, the three groups of values of mass-to-charge ratio (m/z): 369.888, 370.900 and 371.889 indicate [curcumin + H] + isotope; insertion map: predicted [curcumin + H] + isotope, for utilization Measured by SALDI-TOF MS. In the case of mass-to-charge ratios of 369.888, 370.900 and 371.889, the relative peaks of the isotope [curcumin + H] + can be corresponding, indicating that the carbon nano-dots can still be combined after the dialysis (or With / attached) curcumin molecule. In other words, the present invention successfully uses ginger as a carbon source to manufacture/synthesize carbon nano-dots, and after it is made, curcumin can naturally coexist with carbon nano-dots and does not disappear due to dialysis. It solves the problem that curcumin has poor water solubility and is difficult to be prepared into a suitable water-soluble preparation, and is difficult to be fed into cells such as liver cancer cells and liver tumor cells.

請再繼續參閱圖12A、圖12B及圖12C所示,其為碳奈米點對小鼠體內的致瘤性(tumorigenicity)試驗的測試結果,所屬用的小鼠是從國家實驗動物中心(台北,台灣)購得六週齡的BALB/c裸鼠(BALB/cAnN.Cg-Foxn1nu/C-rlNarl),並且飼養在一個特定的無病原體的動物房裡。小鼠的動物實驗獲得動物照護和使用委員會的許可(許可證編號為IACUC2012-037)。在戊巴比妥鈉藥物的麻醉下進行所有手術,以減少小鼠的疼痛。首先,如圖7A的上半圖的箭頭所示,將為數1×107個細胞的HepG2細胞接種到雌性BALB/c小鼠側背部以誘導惡性肝腫瘤產生。當到達接種後的第7天,腫瘤體積將達到約5立方公釐,再進行藥物注射,其中所注射的藥 物以PBS當作對照組(-);以220微克(μg)的碳奈米點作為實驗組(+),分別注入小鼠的腫瘤細胞中進行測試,並於第14天再追加一次上述藥物的注射。測試結果如圖12B所示,腫瘤取出後(在接種後第16天)所呈現的結果,左方為對照組;右方為實驗組。又如圖12C所示,為切除下來的腫瘤秤重(n=3)的量化結果;***indicates p<0.001。在經過14天的且總共接受了440毫克的碳奈米點的注射後,可看見顯著的腫瘤消退情形,碳奈米點確實可在活體達到顯著抑制腫瘤生長的效果,未注射碳奈米點的腫瘤已生長到約104毫克,而體積也持續增大,然而有注射碳奈米點的腫瘤則僅達到約3.7毫克。顯然本發明之碳奈米點具有高通透性和滯留效應(EPR effect),在14天的實驗期間只要注射兩次碳奈米點,碳奈米點便可長久滯留且作用於小鼠體內的腫瘤。而所達到的致瘤性的抑制效果經量化後可達>95%、P<0.001的致瘤性高抑制效果。故經由以上的結果,證明本發明之以薑作為碳源的碳奈米點具有良好的抗癌活性,故利用天然物之薑製造碳奈米點,將可作為一個有效的抗癌藥物,在應用於肝癌的治療上將具有巨大的潛力,因此本發明還提供一種以碳奈米點作為製造治療肝癌疾病/抑制肝腫瘤生長的醫藥的用途,其中本發明之碳奈米點至少包括數個結合於碳奈米點的表面的薑黃素分子,而且所述碳奈米點還融於一含水載體,所述含水載體為一種醫藥上可接受之載體,具體而言,含水載體可為生物體可接受之PBS緩衝溶液、去離子水或生理食鹽水等,但不以此為限,較佳地,本發明之碳奈米點還可被做成一種針劑的類型,以便可透過直接注射的方式而直接對腫瘤產生抑制增殖的效果。 Please continue to refer to FIG. 12A, FIG. 12B and FIG. 12C, which are the results of the test of the tumorigenicity test of the carbon nano-point in mice, and the mouse used is from the National Experimental Animal Center (Taipei). , Taiwan) purchased six-week-old BALB/c nude mice (BALB/cAnN. Cg-Foxn1nu/C-rlNarl ) and were housed in a specific pathogen-free animal room. Animal experiments in mice were obtained under license from the Animal Care and Use Committee (license number IACUC 2012-037). All procedures were performed under anesthesia with sodium pentobarbital to reduce pain in the mice. First, as shown by the arrow in the upper half of Fig. 7A, HepG2 cells of several 1 × 10 7 cells were inoculated into the lateral back of female BALB/c mice to induce malignant liver tumor production. On the 7th day after the inoculation, the tumor volume will reach about 5 cubic centimeters, and then the drug injection, in which the drug is injected with PBS as the control group (-); with 220 micrograms (μg) of carbon nano point As the experimental group (+), the mice were injected into the tumor cells of the mice for testing, and the injection of the above drugs was further added on the 14th day. The test results are shown in Fig. 12B, and the results presented after the tumors were removed (on the 16th day after inoculation) were left control group; the right side was the experimental group. As shown in Fig. 12C, the quantified result of the excised tumor weighing (n = 3); *** indicates p < 0.001. After 14 days of injection and a total of 440 mg of carbon nano-dots, a significant tumor regression was observed, and the carbon nano-dots did achieve significant tumor growth inhibition in vivo, without injection of carbon nano-dots. The tumor has grown to about 104 mg, and the volume has continued to increase, whereas tumors with carbon-injected spots have only reached about 3.7 mg. Obviously, the carbon nano-dots of the present invention have high permeability and retention effect (EPR effect), and the carbon nano-dots can be retained for a long time and act on mice as long as the carbon nano-dots are injected twice during the 14-day experiment. The tumor. The inhibition effect of the tumorigenicity achieved can be quantified to a high tumorigenic effect of >95% and P<0.001. Therefore, it has been confirmed from the above results that the carbon nano point of the present invention using ginger as a carbon source has good anticancer activity, so that the use of natural ginger to produce a carbon nano point can be used as an effective anticancer drug. The invention has great potential for the treatment of liver cancer, and therefore the present invention also provides a use of the carbon nano point as a medicine for treating liver cancer diseases/suppressing growth of liver tumors, wherein the carbon nano point of the present invention includes at least several a curcumin molecule bound to the surface of the carbon nano-dots, and the carbon nano-dots are also fused to an aqueous carrier, the aqueous carrier being a pharmaceutically acceptable carrier, in particular, the aqueous carrier may be an organism An acceptable PBS buffer solution, deionized water or physiological saline solution, etc., but not limited thereto, preferably, the carbon nano point of the present invention can also be made into an injection type so as to be directly permeable. In a way, the tumor directly produces an inhibitory effect on proliferation.

綜上所述,本發明之碳奈米點可由薑製造而得,可在體外及體內的實驗均表現出顯著且具有高度選擇性的HepG2細胞增殖抑制效果,該增殖抑制效果是由ROS的增加並連帶引發p53蛋白質的表現後所導致,使HepG2的細胞週期,顯示具有可發展為肝癌/ 肝腫瘤治療藥物的潛力,同時在體外的細胞實驗的結果也指出本發明之碳奈米點對於其他正常細胞還具有相對較低的細胞毒性,尤其在注射到小鼠體內約1小時後,即可由小鼠的尿液排出其體外,顯示本發明之碳奈米點具有極佳的生物安全性及生物相容性。惟,以上所述僅為本發明之較佳可行實施例,凡依本發明申請專利範圍所做之均等變化與修飾,皆應屬本發明之涵蓋範圍。 In summary, the carbon nano-dots of the present invention can be produced from ginger, and can exhibit significant and highly selective HepG2 cell proliferation inhibitory effects in both in vitro and in vivo experiments, and the proliferation inhibition effect is increased by ROS. And caused by the expression of p53 protein, resulting in the cell cycle of HepG2, showing that it can develop into liver cancer / The potential of therapeutic drugs for liver tumors, as well as the results of cell experiments in vitro, also indicate that the carbon nanopoints of the present invention have relatively low cytotoxicity against other normal cells, especially after about one hour of injection into mice, ie The urine of the mouse can be excreted from the body, indicating that the carbon nano-dots of the present invention have excellent biosafety and biocompatibility. However, the above is only a preferred embodiment of the present invention, and all changes and modifications made to the scope of the present invention should be within the scope of the present invention.

Claims (10)

一種碳奈米點的合成方法,至少包括如下步驟:(A)提供一薑汁,以一預定溫度對該薑汁加熱一預定時間,以使該薑汁碳化,並形成含有碳化物的碳奈米材料;(B)對該含有碳化物的碳奈米材料進行離心以取得上清液;以及(C)過濾該上清液後,對該上清液進行透析處理,從而獲得一碳奈米點懸浮溶液。 A method for synthesizing a carbon nano point, comprising at least the following steps: (A) providing a ginger juice, heating the ginger juice at a predetermined temperature for a predetermined time to carbonize the ginger juice, and forming a carbonaceous carbonaceous material (B) centrifuging the carbide-containing carbon nanomaterial to obtain a supernatant; and (C) filtering the supernatant, and dialysis the supernatant to obtain a carbon nano Point the suspension solution. 如請求項1所述之碳奈米點的合成方法,其中在所述步驟(C),為使用孔徑0.1微米至0.22微米的濾膜以過濾該上清液。 The method for synthesizing a carbon nano-dots according to claim 1, wherein in the step (C), a filter having a pore diameter of 0.1 μm to 0.22 μm is used to filter the supernatant. 如請求項1所述之碳奈米點的合成方法,其中該預定溫度為攝氏280度至320度;該預定時間為100分鐘至140分鐘。 The method for synthesizing a carbon nano-point according to claim 1, wherein the predetermined temperature is 280 to 320 degrees Celsius; and the predetermined time is 100 minutes to 140 minutes. 如請求項1所述之碳奈米點的合成方法,其中在所述步驟(C),為使用分子量限值為3.5kD至5kD的透析膜以對該上清液進行透析處理。 The method for synthesizing a carbon nano-dot as described in claim 1, wherein in the step (C), the supernatant is subjected to dialysis treatment using a dialysis membrane having a molecular weight limit of 3.5 kD to 5 kD. 一種碳奈米點,至少包括:數個結合於該碳奈米點的薑黃素分子。 A carbon nano-point comprising at least: a plurality of curcumin molecules bound to the carbon nano-dots. 如請求項5所述之碳奈米點,其中該碳奈米點的粒徑為3奈米以上至8奈米以下。 The carbon nano-point according to claim 5, wherein the carbon nano-point has a particle diameter of from 3 nm or more to 8 nm or less. 如請求項5所述之碳奈米點,其中該碳奈米點溶於一含水載體。 The carbon nano-dots as claimed in claim 5, wherein the carbon nano-dots are dissolved in an aqueous carrier. 一種以碳奈米點作為製造治療肝腫瘤的醫藥的用途,其中該碳奈米點至少包括:數個結合於該碳奈米點的薑黃素分子,其中該碳奈米點溶於一含水載體。 The invention relates to a carbon nano point as a medicine for manufacturing a liver tumor, wherein the carbon nano point comprises at least: a plurality of curcumin molecules bound to the carbon nano point, wherein the carbon nano point is dissolved in an aqueous carrier . 如請求項8所述之以碳奈米點作為製造治療肝腫瘤的醫藥的用途,其中該碳奈米點的粒徑為3奈米以上至8奈米以下。 The use of the carbon nano point as the medicine for treating a liver tumor as described in claim 8, wherein the carbon nano point has a particle diameter of from 3 nm or more to 8 nm or less. 如請求項8或9所述之以碳奈米點作為製造治療肝腫瘤的醫藥的用途,其中該含水載體為PBS緩衝溶液、去離子水或生理食鹽水。 The use of a carbon nano-dots as claimed in claim 8 or 9 for the manufacture of a medicament for treating liver tumors, wherein the aqueous carrier is PBS buffer solution, deionized water or physiological saline.
TW103109430A 2014-03-14 2014-03-14 Carbon nanodots, method for synthesizing the same and use of producing pharmaceutical agents for treating liver tumor TWI532493B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW103109430A TWI532493B (en) 2014-03-14 2014-03-14 Carbon nanodots, method for synthesizing the same and use of producing pharmaceutical agents for treating liver tumor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW103109430A TWI532493B (en) 2014-03-14 2014-03-14 Carbon nanodots, method for synthesizing the same and use of producing pharmaceutical agents for treating liver tumor

Publications (2)

Publication Number Publication Date
TW201534321A true TW201534321A (en) 2015-09-16
TWI532493B TWI532493B (en) 2016-05-11

Family

ID=54695014

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103109430A TWI532493B (en) 2014-03-14 2014-03-14 Carbon nanodots, method for synthesizing the same and use of producing pharmaceutical agents for treating liver tumor

Country Status (1)

Country Link
TW (1) TWI532493B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110891557A (en) * 2018-06-06 2020-03-17 黄志清 Curcumin carbon quantum dot and application thereof
CN113548656A (en) * 2020-06-16 2021-10-26 哈尔滨成程生命与物质研究所 Carbon dots with anticancer bioactivity and preparation method thereof
WO2022103364A1 (en) * 2020-11-11 2022-05-19 Erciyes Universitesi Carbon nanoparticle synthesis method and use thereof for huvec cancer treatment

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110891557A (en) * 2018-06-06 2020-03-17 黄志清 Curcumin carbon quantum dot and application thereof
CN113548656A (en) * 2020-06-16 2021-10-26 哈尔滨成程生命与物质研究所 Carbon dots with anticancer bioactivity and preparation method thereof
CN113548656B (en) * 2020-06-16 2023-02-21 哈尔滨成程生命与物质研究所 Carbon dots with anticancer bioactivity and preparation method thereof
WO2022103364A1 (en) * 2020-11-11 2022-05-19 Erciyes Universitesi Carbon nanoparticle synthesis method and use thereof for huvec cancer treatment

Also Published As

Publication number Publication date
TWI532493B (en) 2016-05-11

Similar Documents

Publication Publication Date Title
Singh et al. Carbon quantum dots: Synthesis, characterization and biomedical applications
Sarkar et al. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells
Li et al. Carbon dots prepared from ginger exhibiting efficient inhibition of human hepatocellular carcinoma cells
Lu et al. Graphene quantum dots for optical bioimaging
Ghosal et al. Carbon dots: The next generation platform for biomedical applications
Zhu et al. From phosphorus to phosphorene: Applications in disease theranostics
D'souza et al. Synthesis of fluorescent nitrogen-doped carbon dots from dried shrimps for cell imaging and boldine drug delivery system
Wang et al. Targeted imaging and targeted therapy of breast cancer cells via fluorescent double template-imprinted polymer coated silicon nanoparticles by an epitope approach
Chen et al. Diamond nanostructures for drug delivery, bioimaging, and biosensing
Sahoo et al. Simultaneous RGB emitting Au nanoclusters in chitosan nanoparticles for anticancer gene theranostics
Li et al. Green synthesis of gold nanoparticles using aqueous extract of Mentha Longifolia leaf and investigation of its anti-human breast carcinoma properties in the in vitro condition
Fan et al. Fluorescent graphene quantum dots for biosensing and bioimaging
Zare et al. Nonspherical metal‐based nanoarchitectures: synthesis and impact of size, shape, and composition on their biological activity
Zhang et al. Multifunctional hyaluronic acid-derived carbon dots for self-targeted imaging-guided photodynamic therapy
JP2010501002A (en) Rare earth nanoparticles
Bi et al. Doxorubicin-conjugated CuS nanoparticles for efficient synergistic therapy triggered by near-infrared light
Roshini et al. pH-sensitive tangeretin-ZnO quantum dots exert apoptotic and anti-metastatic effects in metastatic lung cancer cell line
US8999294B2 (en) Nanoparticles for use in tumor diagnosis and therapy
Shao et al. Shining light on chiral inorganic nanomaterials for biological issues
WO2013087920A1 (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
Huang et al. Poly-tannic acid coated paclitaxel nanocrystals for combinational photothermal-chemotherapy
TWI532493B (en) Carbon nanodots, method for synthesizing the same and use of producing pharmaceutical agents for treating liver tumor
JP2016526021A (en) Target Koror and MRI for tumor toxicity
Sharma et al. Actin-binding carbon dots selectively target glioblastoma cells while sparing normal cells
Chen et al. Gold nanobipyramid@ copper sulfide nanotheranostics for image-guided NIR-II photo/chemodynamic cancer therapy with enhanced immune response